Medicine & Health

Researchers at the School of Medicine and Whiterabbit.ai have developed a software that assesses breast density and can help identify women who could benefit from additional screening.

In a small study, researchers at Washington University School of Medicine found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients.

A new study from Washington University School of Medicine suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.

Researchers at Washington University School of Medicine in St. Louis have found that a protein involved in regulating lipid levels in the liver and blood also promotes development and progression of fatty liver disease and liver cancer in mice.

Aadel A. Chaudhuri, MD, PhD, assistant professor of radiation oncology at Washington University School of Medicine, has received the V Scholar Award from the V Foundation for Cancer Research.

Washington University’s Mentored Training for Dissemination and Implementation Research in Cancer program, the first of its kind in cancer prevention and control, has resulted in an uptick in skills, grants, publications, networking and even some practice changes.

Cancer cells can survive even after being hit with high doses of chemotherapy or radiation, but a School of Medicine team working to make treatment more effective is focusing on ways to tweak the inner machinery of cancer cells to make them more susceptible to dying.

New research — co-led by Washington University School of Medicine — has identified the most important features of cancer cells’ protein fragments, which can help distinguish the tumor from healthy tissue, enabling researchers to design better immunotherapies, including vaccines.

A consortium of 17 U.S. cancer centers, including Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, are working together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.

In a mouse study, researchers at Washington University School of Medicine in St. Louis have found that an antibody that targets the protein TREM2 empowers tumor-destroying immune cells and improves the effectiveness of cancer immunotherapy.